T2 Biosystems Participates In NIH-Funded Antibacterial Resistance Leadership Group Pilot Study For Pneumonia Patients

Author: Benzinga Newsdesk | January 18, 2024 10:01am

The Pneumonia Direct Pilot study is a prospective, observational, diagnostic, feasibility study to determine the accuracy of multiple pathogen- and host-directed tests for the diagnosis of ventilator-associated pneumonia (VAP). Under the direction of Kimberly Hanson, M.D., University of Utah, the study seeks to explore new approaches for diagnosing VAP along with more comprehensive detection of antibiotic-resistant infections. The feasibility design is intended to inform future interventional studies that will investigate the clinical impact of combined pathogen and host-directed testing approaches.

Posted In: TTOO